Global Arteriosclerosis Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Arteriosclerosis Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Arteriosclerosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Medicine
1.4.3 Surgery
1.5 Market by Application
1.5.1 Global Arteriosclerosis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Arteriosclerosis Therapeutics Market Perspective (2015-2026)
2.2 Arteriosclerosis Therapeutics Growth Trends by Regions
2.2.1 Arteriosclerosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Arteriosclerosis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Arteriosclerosis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Arteriosclerosis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Arteriosclerosis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Arteriosclerosis Therapeutics Players by Market Size
3.1.1 Global Top Arteriosclerosis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Arteriosclerosis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Arteriosclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Arteriosclerosis Therapeutics Market Concentration Ratio
3.2.1 Global Arteriosclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Arteriosclerosis Therapeutics Revenue in 2019
3.3 Arteriosclerosis Therapeutics Key Players Head office and Area Served
3.4 Key Players Arteriosclerosis Therapeutics Product Solution and Service
3.5 Date of Enter into Arteriosclerosis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Arteriosclerosis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Arteriosclerosis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Arteriosclerosis Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
5.2 Global Arteriosclerosis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Arteriosclerosis Therapeutics Market Size (2015-2020)
6.2 Arteriosclerosis Therapeutics Key Players in North America (2019-2020)
6.3 North America Arteriosclerosis Therapeutics Market Size by Type (2015-2020)
6.4 North America Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Arteriosclerosis Therapeutics Market Size (2015-2020)
7.2 Arteriosclerosis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Arteriosclerosis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Arteriosclerosis Therapeutics Market Size (2015-2020)
8.2 Arteriosclerosis Therapeutics Key Players in China (2019-2020)
8.3 China Arteriosclerosis Therapeutics Market Size by Type (2015-2020)
8.4 China Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Arteriosclerosis Therapeutics Market Size (2015-2020)
9.2 Arteriosclerosis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Arteriosclerosis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Arteriosclerosis Therapeutics Market Size (2015-2020)
10.2 Arteriosclerosis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Arteriosclerosis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Arteriosclerosis Therapeutics Market Size (2015-2020)
11.2 Arteriosclerosis Therapeutics Key Players in India (2019-2020)
11.3 India Arteriosclerosis Therapeutics Market Size by Type (2015-2020)
11.4 India Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Arteriosclerosis Therapeutics Market Size (2015-2020)
12.2 Arteriosclerosis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Arteriosclerosis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Arteriosclerosis Therapeutics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview and Its Total Revenue
13.1.3 AstraZeneca Arteriosclerosis Therapeutics Introduction
13.1.4 AstraZeneca Revenue in Arteriosclerosis Therapeutics Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview and Its Total Revenue
13.2.3 Pfizer Arteriosclerosis Therapeutics Introduction
13.2.4 Pfizer Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview and Its Total Revenue
13.3.3 Bayer Arteriosclerosis Therapeutics Introduction
13.3.4 Bayer Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck Arteriosclerosis Therapeutics Introduction
13.4.4 Merck Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview and Its Total Revenue
13.5.3 Novartis Arteriosclerosis Therapeutics Introduction
13.5.4 Novartis Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Sanofi
13.6.1 Sanofi Company Details
13.6.2 Sanofi Business Overview and Its Total Revenue
13.6.3 Sanofi Arteriosclerosis Therapeutics Introduction
13.6.4 Sanofi Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.6.5 Sanofi Recent Development
13.7 Hoffmann-La Roche
13.7.1 Hoffmann-La Roche Company Details
13.7.2 Hoffmann-La Roche Business Overview and Its Total Revenue
13.7.3 Hoffmann-La Roche Arteriosclerosis Therapeutics Introduction
13.7.4 Hoffmann-La Roche Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.7.5 Hoffmann-La Roche Recent Development
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Details
13.8.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.8.3 GlaxoSmithKline Arteriosclerosis Therapeutics Introduction
13.8.4 GlaxoSmithKline Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.8.5 GlaxoSmithKline Recent Development
13.9 Isis Pharmaceuticals
13.9.1 Isis Pharmaceuticals Company Details
13.9.2 Isis Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 Isis Pharmaceuticals Arteriosclerosis Therapeutics Introduction
13.9.4 Isis Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.9.5 Isis Pharmaceuticals Recent Development
13.10 Anthera Pharmaceuticals
13.10.1 Anthera Pharmaceuticals Company Details
13.10.2 Anthera Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Anthera Pharmaceuticals Arteriosclerosis Therapeutics Introduction
13.10.4 Anthera Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
13.10.5 Anthera Pharmaceuticals Recent Development
13.11 Johnson and Johnson
10.11.1 Johnson and Johnson Company Details
10.11.2 Johnson and Johnson Business Overview and Its Total Revenue
10.11.3 Johnson and Johnson Arteriosclerosis Therapeutics Introduction
10.11.4 Johnson and Johnson Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
10.11.5 Johnson and Johnson Recent Development
13.12 Cardium Therapeutics
10.12.1 Cardium Therapeutics Company Details
10.12.2 Cardium Therapeutics Business Overview and Its Total Revenue
10.12.3 Cardium Therapeutics Arteriosclerosis Therapeutics Introduction
10.12.4 Cardium Therapeutics Revenue in Arteriosclerosis Therapeutics Business (2015-2020)
10.12.5 Cardium Therapeutics Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Arteriosclerosis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Arteriosclerosis Therapeutics Revenue
Table 3. Ranking of Global Top Arteriosclerosis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Arteriosclerosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Medicine
Table 6. Key Players of Surgery
Table 7. Global Arteriosclerosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Arteriosclerosis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Arteriosclerosis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Arteriosclerosis Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Arteriosclerosis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Arteriosclerosis Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Arteriosclerosis Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Arteriosclerosis Therapeutics Players
Table 18. Global Arteriosclerosis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Arteriosclerosis Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Arteriosclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arteriosclerosis Therapeutics as of 2019)
Table 21. Global Arteriosclerosis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Arteriosclerosis Therapeutics Product Solution and Service
Table 24. Date of Enter into Arteriosclerosis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Arteriosclerosis Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Arteriosclerosis Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Arteriosclerosis Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Arteriosclerosis Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Arteriosclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Arteriosclerosis Therapeutics Market Share (2019-2020)
Table 34. North America Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Arteriosclerosis Therapeutics Market Share by Type (2015-2020)
Table 36. North America Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Arteriosclerosis Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Arteriosclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Arteriosclerosis Therapeutics Market Share (2019-2020)
Table 40. Europe Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Arteriosclerosis Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Arteriosclerosis Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Arteriosclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Arteriosclerosis Therapeutics Market Share (2019-2020)
Table 46. China Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Arteriosclerosis Therapeutics Market Share by Type (2015-2020)
Table 48. China Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Arteriosclerosis Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Arteriosclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Arteriosclerosis Therapeutics Market Share (2019-2020)
Table 52. Japan Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Arteriosclerosis Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Arteriosclerosis Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Arteriosclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Arteriosclerosis Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Arteriosclerosis Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Arteriosclerosis Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Arteriosclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Arteriosclerosis Therapeutics Market Share (2019-2020)
Table 64. India Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Arteriosclerosis Therapeutics Market Share by Type (2015-2020)
Table 66. India Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Arteriosclerosis Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Arteriosclerosis Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Arteriosclerosis Therapeutics Market Share (2019-2020)
Table 70. Central & South America Arteriosclerosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Arteriosclerosis Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Arteriosclerosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Arteriosclerosis Therapeutics Market Share by Application (2015-2020)
Table 74. AstraZeneca Company Details
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Product
Table 77. AstraZeneca Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 78. AstraZeneca Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Product
Table 87. Bayer Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 88. Bayer Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Product
Table 102. Sanofi Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 103. Sanofi Recent Development
Table 104. Hoffmann-La Roche Company Details
Table 105. Hoffmann-La Roche Business Overview
Table 106. Hoffmann-La Roche Product
Table 107. Hoffmann-La Roche Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 108. Hoffmann-La Roche Recent Development
Table 109. GlaxoSmithKline Business Overview
Table 110. GlaxoSmithKline Product
Table 111. GlaxoSmithKline Company Details
Table 112. GlaxoSmithKline Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 113. GlaxoSmithKline Recent Development
Table 114. Isis Pharmaceuticals Company Details
Table 115. Isis Pharmaceuticals Business Overview
Table 116. Isis Pharmaceuticals Product
Table 117. Isis Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 118. Isis Pharmaceuticals Recent Development
Table 119. Anthera Pharmaceuticals Company Details
Table 120. Anthera Pharmaceuticals Business Overview
Table 121. Anthera Pharmaceuticals Product
Table 122. Anthera Pharmaceuticals Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 123. Anthera Pharmaceuticals Recent Development
Table 124. Johnson and Johnson Company Details
Table 125. Johnson and Johnson Business Overview
Table 126. Johnson and Johnson Product
Table 127. Johnson and Johnson Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 128. Johnson and Johnson Recent Development
Table 129. Cardium Therapeutics Company Details
Table 130. Cardium Therapeutics Business Overview
Table 131. Cardium Therapeutics Product
Table 132. Cardium Therapeutics Revenue in Arteriosclerosis Therapeutics Business (2015-2020) (Million US$)
Table 133. Cardium Therapeutics Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Arteriosclerosis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Global Arteriosclerosis Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Arteriosclerosis Therapeutics Report Years Considered
Figure 9. Global Arteriosclerosis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Arteriosclerosis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Arteriosclerosis Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Arteriosclerosis Therapeutics Market Share by Players in 2019
Figure 14. Global Top Arteriosclerosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arteriosclerosis Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Arteriosclerosis Therapeutics Revenue in 2019
Figure 16. North America Arteriosclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Arteriosclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Arteriosclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Arteriosclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Arteriosclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Arteriosclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Arteriosclerosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AstraZeneca Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 25. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Pfizer Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 27. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bayer Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 29. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Novartis Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sanofi Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 35. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Hoffmann-La Roche Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 37. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. GlaxoSmithKline Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 39. Isis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Isis Pharmaceuticals Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 41. Anthera Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Anthera Pharmaceuticals Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 43. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Johnson and Johnson Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 45. Cardium Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Cardium Therapeutics Revenue Growth Rate in Arteriosclerosis Therapeutics Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed